Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement
Delay to Diagnosis and Management in Digestive Cancerology by the General Practitioner Within the City-hospital Network in the Context of Confinement Related to the Covid-19 Pandemic
1 other identifier
observational
376
1 country
1
Brief Summary
Objective: the pre-hospital management of cancers is little known in General Medicine. The first lockdown related to the COVID-19 pandemic led to the closure of health facilities. Investigators were interested in the diagnosis and care pathway of digestive cancers in post-confinement in General Medicine in Nouvelle-Aquitaine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 25, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedNovember 7, 2023
November 1, 2023
3.3 years
October 25, 2023
November 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
time from date of first symptoms of cancer to the date of first MDT
time from date of first symptoms of cancer to the date of first MDT
DAYS
Secondary Outcomes (6)
time from date of first symptoms to date of first consultation with a general practitioner,
DAYS
time from date of first symptoms to first imaging or specific examination,
DAYS
time from date of first symptoms to consultation with a specialist,
DAYS
stage of pathology by type of cancer,
at inclusion
frequency of different types of cancer,
at inclusion
- +1 more secondary outcomes
Study Arms (2)
2019
patients diagnosed in 2019
2020
patients diagnosed in 2020
Eligibility Criteria
Male and female under 18 years old * residing in New Aquitaine and * whose general practitioner practiced in New Aquitaine * malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas. * to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.
You may qualify if:
- residing in New Aquitaine and
- whose general practitioner practiced in New Aquitaine
- malignant tumors of the esophagus, stomach, small intestine, colon, recto-sigmoid junction, rectum, anus and anal canal, liver and intrahepatic bile ducts, extrahepatic bile ducts, gallbladder and pancreas.
- to have had at least one consultation or hospitalization in the digestive pole of the Bordeaux University Hospital within 6 months after the MDT.
You may not qualify if:
- Patients under 18 years of age,
- who had already had a MDT for this cancer,
- whose new cancer was a digestive metastasis of a primary of another location,
- who did not have French health insurance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Blanc-Bisson Christele
Bordeaux, 33076, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 25, 2023
First Posted
November 7, 2023
Study Start
June 1, 2019
Primary Completion
September 1, 2022
Study Completion
September 1, 2022
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share